Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds
Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds
复制标题
作为抗 HIV-1 化合物的新型三萜衍生物的设计、合成和生物评价
DOI:
10.1016/j.bmcl.2022.128768
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Narumi Tetsuo
中科院分区:
文献类型:
--
作者:
Takeuchi Reon;Ogihara Kasumi;Fujimoto Junko;Sato Kohei;Mase Nobuyuki;Yoshimura Kazuhisa;Harada Shigeyoshi;Narumi Tetsuo
Two betulinic acid derivatives, RPR103611 (2) and IC9564 (3) were previously reported to be potent HIV-1 entry inhibitors. In this current study, a SAR study of the triterpenoid moiety of2and3has been performed and an oleanolic acid derivative (4)was identified as a novel HIV-1 entry inhibitor. In addition, the combination of4with several-type of HIV-1 neutralizing antibodies provided significant synergistic effects. The synthetic utility of the Cdouble bondC double bond in the C-ring of4was also demonstrated to develop the 12-keto-type oleanolic acid derivative (5) as a potent anti-HIV compound. This simple transformation led to a significantly increased anti-HIV activity and a reduced cytotoxicity of the compound.